PDF Publication Title:
Text from PDF Page: 011
Wei et al. Page 11 51. Sotiriou GA, et al. Non-toxic dry-coated nanosilver for plasmonic biosensors. Adv Functional Mater. 2010; 20:4250–4257. 52. George S, et al. Surface defects on plate-shaped silver nanoparticles contribute to its hazard potential in a fish gill cell line and zebrafish embryos. ACS Nano. 2012; 6:3745–3759. [PubMed: 22482460] 53. Ikramullah A, et al. In vitro cytotoxicity testing of silver nano-particles in lymphocyte and sperm cells. Ind J Fund Appl Life Sci. 2013; 3:44–47. 54. Tran QH, et al. Silver nanoparticles: synthesis, properties, toxicology, applications and perspectives. Adv Nat Sci Nanosci Nanotechnol. 2013; 4:20. 55. dos Santos CA, et al. Silver nanoparticles: therapeutical uses, toxicity, and safety issues. J Pharm Sci. 2014; 103:1931–1944. [PubMed: 24824033] 56. Park S, et al. Antiviral properties of silver nanoparticles on a magnetic hybrid colloid. Appl Environ Microbiol. 2014; 80:2343–2350. [PubMed: 24487537] 57. Xiang D, et al. Inhibition of A/Human/Hubei/3/2005 (H3N2) influenza virus infection by silver nanoparticles in vitro and in vivo. Int J Nanomed. 2013; 8:4103–4114. 58. Gaikwad S, et al. Antiviral activity of mycosynthesized silver nanoparticles against herpes simplex virus and human parainfluenza virus type 3. Int J Nanomed. 2013; 8:4303–4314. 59. Trefry JC, Wooley DP. Silver nanoparticles inhibit vaccinia virus infection by preventing viral entry through a macropinocytosis-dependent mechanism. J Biomed Nanotechnol. 2013; 9:1624– 1635. [PubMed: 23980510] 60. Lima RD, et al. Silver nanoparticles: a brief review of cytotoxicity and genotoxicity of chemically and biogenically synthesized nanoparticles. J Appl Toxicol. 2012; 32:867–879. [PubMed: 22696476] 61. Gurunathan S, et al. Antiangiogenic properties of silver nanoparticles. Biomaterials. 2009; 30:6341–6350. [PubMed: 19698986] 62. Sriram MI, et al. Antitumor activity of silver nanoparticles in Dalton’s lymphoma ascites tumor model. Int J Nanomed. 2010; 5:753–762. 63. Guo D, et al. The cellular uptake and cytotoxic effect of silver nanoparticles on chronic myeloid leukemia cells. J Biomed Nanotechnol. 2014; 10:669–678. [PubMed: 24734519] 64. Franco-Molina MA, et al. Antitumor activity of colloidal silver on MCF-7 human breast cancer cells. J Exp Clin Cancer Res. 2010; 29:148–154. [PubMed: 21080962] 65. Gurunathan S, et al. Cytotoxicity of biologically synthesized silver nanoparticles in MDA-MB-231 human breast cancer cells. Biomed Res Int. 2013:535796–535805. [PubMed: 23936814] 66. Gurunathan S, et al. Green synthesis of silver nanoparticles using Ganoderma neo-japonicum Imazeki: a potential cytotoxic agent against breast cancer cells. Int J Nanomed. 2013; 8:4399– 4413. 67. Sahu SC, et al. Comparative cytotoxicity of nanosilver in human liver HepG2 and colon Caco2 cells in culture. J Appl Toxicol. 2014; 34:1155–1166. [PubMed: 24522958] 68. Faedmaleki F, et al. Toxicity effect of silver nanoparticles on mice liver primary cell culture and HepG2 cell line. Iran J Pharm Res. 2014; 13:235–242. [PubMed: 24734076] 69. Foldbjerg R, et al. Cytotoxicity and genotoxicity of silver nanoparticles in the human lung cancer cell line, A549. Arch Toxicol. 2011; 85:743–750. [PubMed: 20428844] 70. Nazir S, et al. Novel and cost-effective green synthesis of silver nano particles and their in vivo antitumor properties against human cancer cell lines. J Biosci Tech. 2011; 2:425–430. 71. Austin LA, et al. Nuclear targeted silver nanospheres perturb the cancer cell cycle differently than those of nanogold. Bioconjugate Chem. 2011; 22:2324–2331. Drug Discov Today. Author manuscript; available in PMC 2016 May 01. Author Manuscript Author Manuscript Author Manuscript Author ManuscriptPDF Image | Silver nanoparticles: synthesis, properties, therapeutic apps
PDF Search Title:
Silver nanoparticles: synthesis, properties, therapeutic appsOriginal File Name Searched:
nihms651778.pdfDIY PDF Search: Google It | Yahoo | Bing
Turbine and System Plans CAD CAM: Special for this month, any plans are $10,000 for complete Cad/Cam blueprints. License is for one build. Try before you buy a production license. More Info
Waste Heat Power Technology: Organic Rankine Cycle uses waste heat to make electricity, shaft horsepower and cooling. More Info
All Turbine and System Products: Infinity Turbine ORD systems, turbine generator sets, build plans and more to use your waste heat from 30C to 100C. More Info
CO2 Phase Change Demonstrator: CO2 goes supercritical at 30 C. This is a experimental platform which you can use to demonstrate phase change with low heat. Includes integration area for small CO2 turbine, static generator, and more. This can also be used for a GTL Gas to Liquids experimental platform. More Info
Introducing the Infinity Turbine Products Infinity Turbine develops and builds systems for making power from waste heat. It also is working on innovative strategies for storing, making, and deploying energy. More Info
Need Strategy? Use our Consulting and analyst services Infinity Turbine LLC is pleased to announce its consulting and analyst services. We have worked in the renewable energy industry as a researcher, developing sales and markets, along with may inventions and innovations. More Info
Made in USA with Global Energy Millennial Web Engine These pages were made with the Global Energy Web PDF Engine using Filemaker (Claris) software.
Infinity Turbine Developing Spinning Disc Reactor SDR or Spinning Disc Reactors reduce processing time for liquid production of Silver Nanoparticles.
CONTACT TEL: 608-238-6001 Email: greg@infinityturbine.com (Standard Web Page)